Prevention program for Clostridium difficile infection: a single-centre Serbian experience

被引:1
|
作者
Brkic, Snezana [1 ]
Pellicano, Rinaldo [2 ]
Turkulov, Vesna [1 ]
Radovanovic, Marija [3 ]
Abenavoli, Ludovico [4 ]
机构
[1] Univ Novi Sad, Med Fac Novi Sad, Clin Ctr Vojvodina Infect Dis, Novi Sad, Serbia
[2] Molinette Mauriziano Hosp, Dept Gastrohepatol, Turin, Italy
[3] Miofarm Doo, Novi Sad, Serbia
[4] Magna Graecia Univ Catanzaro, Dept Hlth Sci, Catanzaro, Italy
关键词
Clostridium dffficile; Infection; Prevention and control; Hospitals; ECONOMIC BURDEN; DISEASE; EPIDEMIOLOGY; COSTS; MANAGEMENT; DIAGNOSIS; DIARRHEA; HOSPITALS; EUROPE;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND: Clostridium difficile (C. difficile) diarrhea is a common, iatrogenic, nosocomial disease with a worldwide diffusion. Recent studies reported that the incidence of C. difficile infection (CDI) is rising, due to aging of the population and to greater prevalence of hypervirulent strains. We investigated whether the application of a prevention program lead to a decline in the incidence of intrahospital CDI. METHODS: The study was designed as observational, to compare the efficacy of Schillke preventive program with the standard protocols, in a period of 4 months. For every patient with community-onset healthcare facility-associated (HCFA) CDI, we randomly selected four controls (1:4) with the same ICD code but without HCFA CDI. For statistical analysis the nonparametric, one-way ANOVA, univariate regression analysis, univariate analysis of variance, and Welch and Brown-Forsythe Test were used. RESULTS: Clinical features of HCFA CDI were typical. HCFA CDI group was significantly older than control group (P=0.008 and F=6.686; Partial Eta Square=0.013). Patients with HCFA CDI stayed significantly longer in hospital (P=0.000 and F=69.379; Partial Eta Square=0.117). Acquiring CDI prolonged the hospitalization of 14.52 days. HCFA CDI significantly increases the total cost of hospitalization as well as each element of the price respectively. With the application of the prevention program the annual incidence of CDI dropped from 49.01 in 2013 to 18.22/10000 bed days in 2014. CONCLUSIONS: Applying Schulke preventive program, implemented in 2014, has led to significant savings for the hospital compared to previous methods.
引用
收藏
页码:131 / 139
页数:9
相关论文
共 50 条
  • [31] Vaccines in development for the primary prevention of Clostridium difficile infection
    Legenza, Laurel M.
    Barnett, Susanne G.
    Rose, Warren E.
    JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION, 2017, 57 (04) : 547 - 549
  • [32] Clostridium Difficile Infection Prevention, Treatment, and Surgical Management
    Luciano, Jason A.
    Zuckerbraun, Brian S.
    SURGICAL CLINICS OF NORTH AMERICA, 2014, 94 (06) : 1335 - +
  • [33] Cytomegalovirus infection in a single-centre Australian neonatal cohort
    Seneviratne, Maheesha
    Fernando, Malindu E.
    Kandasamy, Yogavijayan
    White, Andrew
    Sabesan, Vanaja
    Norton, Robert
    JOURNAL OF PAEDIATRICS AND CHILD HEALTH, 2022, 58 (07) : 1136 - 1144
  • [34] Infection prevention and control practices related to Clostridium difficile infection in Canadian acute and long-term care institutions
    Wilkinson, Krista
    Gravel, Denise
    Taylor, Geoffrey
    McGeer, Allison
    Simor, Andrew
    Suh, Kathryn
    Moore, Dorothy
    Kelly, Sharon
    Boyd, David
    Mulvey, Michael
    Mounchili, Aboubakar
    Miller, Mark
    AMERICAN JOURNAL OF INFECTION CONTROL, 2011, 39 (03) : 177 - 182
  • [35] Prevention of Clostridium difficile infection in hamsters using a non-toxigenic strain
    de Oliveira Junior, Carlos Augusto
    Silveira Silva, Rodrigo Otavio
    Diniz, Amanda Nadia
    Pires, Prhiscylla Sadana
    Faria Lobato, Francisco Carlos
    de Assis, Ronie Antunes
    CIENCIA RURAL, 2016, 46 (05): : 853 - 859
  • [36] Health Care-Associated Clostridium difficile Infection in Adults Admitted to Acute Care Hospitals in Canada: A Canadian Nosocomial Infection Surveillance Program Study
    Gravel, Denise
    Miller, Mark
    Simor, Andrew
    Taylor, Geoffrey
    Gardam, Michael
    McGeer, Allison
    Hutchinson, James
    Moore, Dorothy
    Kelly, Sharon
    Boyd, David
    Mulvey, Michael
    CLINICAL INFECTIOUS DISEASES, 2009, 48 (05) : 568 - 576
  • [37] Clostridium difficile Infection: An Orthopaedic Surgeon's Guide to Epidemiology, Management, and Prevention
    Anderson, Paul A.
    Bernatz, James
    Safdar, Nasia
    JOURNAL OF THE AMERICAN ACADEMY OF ORTHOPAEDIC SURGEONS, 2017, 25 (03) : 214 - 223
  • [38] Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection in Patients at Increased Risk for Recurrence
    Gerding, Dale N.
    Kelly, Ciaran P.
    Rahav, Galia
    Lee, Christine
    Dubberke, Erik R.
    Kumar, Princy N.
    Yacyshyn, Bruce
    Kao, Dina
    Eves, Karen
    Ellison, Misoo C.
    Hanson, Mary E.
    Guris, Dalya
    Dorr, Mary Beth
    CLINICAL INFECTIOUS DISEASES, 2018, 67 (05) : 649 - 656
  • [39] Early recognition of aggressive pituitary adenomas: a single-centre experience
    Ceccato, Filippo
    Regazzo, Daniela
    Barbot, Mattia
    Denaro, Luca
    Emanuelli, Enzo
    Borsetto, Daniele
    Rolma, Giuseppe
    Alessio, Luigi
    Gardiman, Marina Paola
    Lombardi, Giuseppe
    Albiger, Nora
    D'Avella, Domenico
    Scaroni, Carla
    ACTA NEUROCHIRURGICA, 2018, 160 (01) : 49 - 55
  • [40] Non-Hodgkin lymphoma in Romania: a single-centre experience
    Fetica, Bogdan
    Achimas-Cadariu, Patriciu
    Pop, Bogdan
    Dima, Delia
    Petrov, Ljubomir
    Perry, Anamarija M.
    Nathwani, Bharat N.
    Mueller-Hermelink, Hans K.
    Diebold, Jacques
    MacLennan, Kenneth A.
    Fulop, Annamaria
    Blaga, Mihaiela L.
    Coza, Daniela
    Al Nicula, Florian
    Irimie, Alexandru
    Weisenburger, Dennis D.
    HEMATOLOGICAL ONCOLOGY, 2017, 35 (02) : 198 - 205